RuneB Strandby

Rigshospitalet

Papers

1

Total Citations

6

H-Index

1

About

RuneB Strandby is a clinical researcher whose work centers on the surgical oncology of gastroesophageal junction (GEJ) cancer, with a particular focus on peritoneal tumor dissemination. His most cited study, published in 2019, investigates the incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in GEJ cancer patients. This work addresses a critical gap in the field, as the utility of peritoneal washing cytology in this specific patient population had not been thoroughly evaluated. By systematically determining how neoadjuvant treatment alters the presence of malignant cells in the peritoneal cavity, Strandby’s research provides essential insights for staging, prognosis, and treatment planning. Although his citation count is still growing, this foundational study has garnered 6 citations, reflecting its relevance to surgeons and oncologists seeking to refine therapeutic strategies. Strandby’s contributions help clarify the role of peritoneal cytology in guiding clinical decisions, ultimately aiming to improve outcomes for patients with this challenging malignancy. His work represents a valuable step toward more personalized and evidence-based management of GEJ cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
The incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in gastroesophageal junction cancer
6 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Rigshospitalet

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago